ENANTA PHARMACEUTICALS INC·4

Dec 5, 9:08 PM ET

Luly Jay R. 4

4 · ENANTA PHARMACEUTICALS INC · Filed Dec 5, 2023

Insider Transaction Report

Form 4
Period: 2023-12-01
Luly Jay R.
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2023-12-01$9.49/sh5,787$54,919814,023 total
Footnotes (1)
  • [F1]Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit awards granted on November 20, 2020 and November 19, 2021.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES